Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids.
about
Subunit arrangement in the human 20S proteasomeAnalysis of mammalian 20S proteasome biogenesis: the maturation of beta-subunits is an ordered two-step mechanism involving autocatalysisEpoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activityThe 26S proteasome is a multifaceted target for anti-cancer therapiesCore protein of pestiviruses is processed at the C terminus by signal peptide peptidase.Differential global structural changes in the core particle of yeast and mouse proteasome induced by ligand bindingA Minimal β-Lactone Fragment for Selective β5c or β5i Proteasome InhibitorsIdentification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation.The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing.Interaction of Hsp90 with 20S proteasome: thermodynamic and kinetic characterizationPhosphorylation of ATPase subunits of the 26S proteasomeThe ubiquitin-proteasome pathway and proteasome inhibitorsThe proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides.Intrinsic nucleoside diphosphate kinase-like activity is a novel function of the 20 S proteasome.Identification of novel HLA-B27 ligands derived from polymorphic regions of its own or other class I molecules based on direct generation by 20 S proteasome.The caspase-like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites.EpiJen: a server for multistep T cell epitope prediction.Distinct specificities of Mycobacterium tuberculosis and mammalian proteasomes for N-acetyl tripeptide substrates.Effect of high hydrostatic pressures on 20S proteasome activity.Discovery of novel proteasome inhibitors using a high-content cell-based screening systemReduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body DementiaBiochemical characterization of the 20S proteasome from the methanoarchaeon Methanosarcina thermophila.CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathwayThe proteasome activator 11 S REG (PA28) and class I antigen presentationThe specificity of proteasomes: impact on MHC class I processing and presentation of antigens.Proteolysis and class I major histocompatibility complex antigen presentation.The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors.Proteasome activity is required for anthrax lethal toxin to kill macrophagesProteasome inhibitors: from in vitro uses to clinical trials.Puromycin-sensitive aminopeptidase. Sequence analysis, expression, and functional characterization.The ubiquitin-proteasome system and its role in ethanol-induced disorders.Inhibitor-binding mode of homobelactosin C to proteasomes: new insights into class I MHC ligand generation.Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants.Hepatic cytochrome P450 degradation: mechanistic diversity of the cellular sanitation brigade.The proteasome: a novel therapeutic target in haematopoietic malignancy.Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII.Proteasome-dependent endoplasmic reticulum-associated protein degradation: an unconventional route to a familiar fateActivation of the cell death program by inhibition of proteasome functionMisfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome.Targeting the proteasome in mantle cell lymphoma: a promising therapeutic approach.
P2860
Q24311953-BCA36FA0-A0A3-4B72-8EC7-D1C992A67A7EQ24561722-EA3645CC-FFDB-4645-8C66-BD0E7E9D54FCQ24679238-943A95BF-C0A6-48F1-8B3B-15D17171AF3FQ26795764-5B2935D5-0749-4796-9802-6D3D5501C5EFQ27472924-3ED25255-1F19-4371-B0CB-0C1F873A531AQ27684495-600EB9C6-4535-413D-8AE0-27D542B5D75CQ27700842-9B529196-A167-42CD-A07E-1B6874C5F493Q27932645-BC7FDB34-D267-4436-808C-A994EEFE85E2Q27939678-5485C362-6E5B-43EC-A596-E3470CC648B1Q28214346-C47D5900-708B-4F72-AACE-97FEBF9625A4Q28278235-CB6E75B7-5B8A-46ED-98CD-61D29FA8624AQ28367002-FABBD29E-48C8-4C37-8E2E-0DC126C9F83CQ30453898-7C690AE9-3229-4922-9B1D-C8BA6DCD64B1Q30584585-EEE17C2A-9700-4E7A-BD4A-B76A12B17544Q30685469-A452C45C-BCF2-4F74-9DDC-CBE46F2C1D0DQ33187465-B69AB602-962F-44F1-A471-54713571A888Q33236277-19D2AE0B-F53D-4CAB-8F2C-8BA4BE521DEEQ33373239-F74A147B-BB1C-4B5A-904A-516953417A7BQ33420847-5F67AFA8-94B0-4067-912A-D6F5C02E3ADAQ33521189-7B19655C-51EC-4656-8368-DA6AA55FBBB3Q33708946-AC073800-DD95-4B8B-9D88-05DFD8688A1CQ33726998-DBDAE258-9DE9-4BDD-A1B9-21C380EB6FE6Q33782459-76782B31-327F-4C01-B6D6-4A7BEC57F8DFQ33796158-414C6DE0-E103-4416-8691-481D910114D8Q33815363-21879A7A-A789-4C4F-B424-4A24347531E0Q33815369-FB8EC345-0974-402D-AC13-55FC3323D733Q33892755-B738165F-5FF6-4C54-9804-7C0D46D0D2B7Q34001220-E6B9B23A-FA42-4803-999A-5006BD45613BQ34052405-E0BC945F-6691-4C18-93B7-A578EF81045CQ34298336-B32626D0-C56D-49E0-B601-ACC11E701E14Q34568455-072A4294-6649-4D36-B868-35182B8887ABQ34574839-4534842F-51C5-435D-B97B-A1F16E5A9B2FQ34753108-F2025ED0-0827-462F-B89D-1DF42B2F53B1Q35213373-A072B822-7E3E-494D-8664-CE59798D2E91Q35552523-616ED474-ABDA-48B8-A833-A859E59F11CCQ35821221-A4E621C9-6E22-44F0-BF8B-8ED0CD30E116Q35931446-3DE2365C-8934-4F4F-823A-F34CEC15F3E9Q35964722-C89D8774-373C-4FC4-ADD7-E9F7E3A9B7FDQ36027129-39BEEFC3-D801-45CB-83AF-D32860B8A805Q36328428-8DA553AA-4236-41D9-9832-E4C055D4B564
P2860
Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Evidence for the presence of f ...... and small neutral amino acids.
@en
Evidence for the presence of f ...... and small neutral amino acids.
@nl
type
label
Evidence for the presence of f ...... and small neutral amino acids.
@en
Evidence for the presence of f ...... and small neutral amino acids.
@nl
prefLabel
Evidence for the presence of f ...... and small neutral amino acids.
@en
Evidence for the presence of f ...... and small neutral amino acids.
@nl
P2093
P356
P1433
P1476
Evidence for the presence of f ...... and small neutral amino acids.
@en
P2093
P304
P356
10.1021/BI00057A022
P407
P577
1993-02-01T00:00:00Z